IMMUNO-BIOLOGICAL LABORATORIES CO revenue for the last year amounted to 812.00 M JPY, the most of which — 812.85 M JPY — came from its highest performing source at the moment, Antibody, the year earlier bringing 790.60 M JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought IMMUNO-BIOLOGICAL LABORATORIES CO 549.71 M JPY, and the year before that — 537.89 M JPY.